Cited by — The ALK inhibitor lorlatinib attenuates lipopolysaccharide-induced neuroinflammation by inhibiting microglial activation and preserving blood–brain barrier integrity | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite The ALK inhibitor lorlatinib attenuates lipopolysaccharide-induced neuroinflammation by inhibiting microglial activation and preserving blood–brain barrier integrity.
No admitted local citation edges point to this work yet.
